News & Events
Game Changing Diagnostic and Prognostic Prostate Cancer Genetic Tests Revealed by Jefferson's Kimmel Cancer Center
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes...
Promising Drug Slows Down Advance of Parkinson's Disease and Improves Symptoms
GM1 ganglioside slowed progression of disease in patients over at least a two-year period.
Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize
Two-day symposium Nov. 29 and 30 will focus on individualized medicine.
New Tumor Tracking Technique May Improve Outcomes for Lung Cancer Patients
Real-time approach tracks and radiates moving tumors and spares healthy tissue.
NCI Awards 'Provocative Questions' Grant to Thomas Jefferson University Researcher Scott Waldman
Scott Waldman, MD, PhD, chairman of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded one of the prestigious "Provocative...
Thomas Jefferson University Awarded NIH Grant to Study Fibrotic Skin Disease Caused by MRI Contrast Agents
Researchers at the Jefferson Institute of Molecular Medicine were awarded almost $384,000 by the National Institutes of Health to investigate the mechanisms involved in the development of a serious...
Stat5 Predicts Outcomes for Prostate Cancer Patients after Radical Prostatectomy
Growth protein could serve as a biomarker to help guide prostate cancer treatment, say Jefferson's Kimmel Cancer Center researchers.
Loss of Protective Heart Failure Protein Linked to Critical Limb Ischemia
Restoring diminished levels of a protein shown to prevent and reverse heart failure damage could also have therapeutic applications for patients with critical limb ischemia (CLI), suggests a new...
Recovering 'Bodyguard' Cells in Pancreas May Restore Insulin Production in Diabetics
The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the...
1st Annual Diabetes Symposium: New Advances and Innovations Draws Industry Leaders to Thomas Jefferson University Hospital
Key national and international players on the front lines of diabetes research, care and prevention will descend on Philadelphia...